Isolation and identification of phenolic compounds from Eugenia caryophyllus and study on its biological effect against Macrophomina phaseolina

Clove is one of the oldest and most famous spices. Its seeds resemble nails. It is used in medicinal fields, but its fungicidal activity is unknown. The aim of the study was to test the inhibitory activity of phenolic extracts of cloves against the pathogenic fungus Macrophomina phaseolina.    The research was conducted under laboratory conditions to test the inhibitory ability of Eugenia caryophyllus phenolic extracts on the fungus M. phaseolina, which was partially diagnosed on strawberry plants based on Polymerase chain reaction (PCR) technique, in addition to its morphological and microscopic characteristics. The active compounds present The active compounds (Chlorogenic acid, Qurcetine, Gallic acid, Apigenin, Caffeic acid, Ferulic acid, Kaempferol, Rutin, Catechine) present in the extract of Industrial Methylated Spirit (IMS) separated from cloves were determined using High-performance liquid chromatography (HPLC). and active compounds of IMS phenols) Qurcetine, Apigenin, Ferulic acid, Kaempferol. (The inhibitory effect of phenols extracted from E. caryophyllus against M. phaseolina was tested. The results showed that the acetone extract and acetone phenols, which were used at concentrations of 10 and 15 mg/ml in PDA medium, had a significant effect on the growth of the fungus by 100%, as these fungi failed to grow. Formation of spores on Peptone dextrose medium (PDA) medium. While the percentage of inhibition of acetone phenols was 25% at a concentration of 5 mg/ml. As for the IMS extract and IMS phenols, it had a significant effect on the growth of the fungus at all concentrations used, but with different inhibition ratios, which increased directly with increasing concentration of the extract.

<span style="font-size:11.0pt;mso-bidi-font-size: 10.0pt;font-family:"Times New Roman";mso-fareast-font-family:"Times New Roman"; letter-spacing:-.1pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-US; mso-bidi-language:AR-SA" lang="EN-GB">Intermolecular interaction in the benzene-Ar_n and benzene dimer van der Waals complexes: DFT analysis of the charge distribution and electric response properties</span>

19-27The performance of the DFT/B-97-D and <span style="font-family:Symbol;mso-ascii-font-family: " times="" new="" roman";mso-hansi-font-family:"times="" roman";letter-spacing:-.1pt;="" mso-char-type:symbol;mso-symbol-font-family:symbol"="" lang="EN-GB">wB97-D methods to reproduce the isotropic non-bonded interaction and the electric response properties in the benzene–argon and the π-π interaction in the benzene dimer have been studied. The PES for the interaction of benzene and argon with all possible Arn-benzene (n = 1, 2) conformations has been explored. Results indicate that the <span style="font-family: Symbol;mso-ascii-font-family:" times="" new="" roman";mso-hansi-font-family:"times="" roman";="" letter-spacing:-.1pt;mso-char-type:symbol;mso-symbol-font-family:symbol"="" lang="EN-GB">wB97-XD method is capable of reproducing well positions and depths for the studied benzene-Ar and benzene-benzene clusters to a high degree of accuracy and compare well with the experimental and best benchmark calculations. Satisfactory results have also been obtained for the benzene-X (X = He, Ne and Kr) clusters. The features of the charge density distributions of the studied benzene-Ar van der Waal complexes have been analyzed by calculating the dipole and higher multipole moments and the static polarizibility, its anistropic part and the interaction polarizibility. Trends and relationships to the dispersion interaction energy are suggested. Natural bond orbital analyses of the benzene-Arn vdw complexes show clearly that all carbon valence orbitals are over-populated by about 21% at the expense of the hydrogen atoms valence orbitals. These data also indicate that argon behaves as electron donor in the Ar-benzene vdw complex, and hence, the slight positive charge on argon is at on the expense of its valence (non-bonding) p-orbitals. </span

Cystic fibrosis on the African continent

Cystic fibrosis (CF; OMIM 219700) is a life-shortening and costly autosomal recessive disease that has been most extensively studied in individuals of Caucasian descent. There is ample evidence, however, that it also affects other ethnicities. In Africa there have been several reports of CF, but there has been no concerted effort toward establishing the molecular epidemiology of this disease on the continent, which is the first step toward outlining a public health strategy to effectively address the needs of these patients. A literature search revealed reports from only 12 of the 54 African states on the molecular analysis of the mutations present in suspected CF patients, resulting in the identification of 79 mutations. Based on previous functional investigations, 39 of these cause CF, 10 are of varying clinical consequence, 4 have no associated evidence regarding whether they cause CF, 4 are synonymous, 5 are novel, and 21 are unique to Africa. We propose that CF be more thoroughly investigated on the continent to ensure that the public health needs of African CF patients—both those in Africa and those of African descent living elsewhere—are met.The University of Pretoria Vice-Chancellor’s Post-doctoral Research Programme, the Institute for Cellular and Molecular Medicine at the University of Pretoria and the Genomics Research Institute (a University of Pretoria Institutional Research Theme).2017-01-31hb2016Immunolog

Connecting the Human Variome Project to nutrigenomics

Nutrigenomics is the science of analyzing and understanding gene–nutrient interactions, which because of the genetic heterogeneity, varying degrees of interaction among gene products, and the environmental diversity is a complex science. Although much knowledge of human diversity has been accumulated, estimates suggest that ~90% of genetic variation has not yet been characterized. Identification of the DNA sequence variants that contribute to nutrition-related disease risk is essential for developing a better understanding of the complex causes of disease in humans, including nutrition-related disease. The Human Variome Project (HVP; http://www.humanvariomeproject.org/) is an international effort to systematically identify genes, their mutations, and their variants associated with phenotypic variability and indications of human disease or phenotype. Since nutrigenomic research uses genetic information in the design and analysis of experiments, the HVP is an essential collaborator for ongoing studies of gene–nutrient interactions. With the advent of next generation sequencing methodologies and the understanding of the undiscovered variation in human genomes, the nutrigenomic community will be generating novel sequence data and results. The guidelines and practices of the HVP can guide and harmonize these efforts

Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countries

Purpose: We aimed to compare the incidence of stroke in low-and middle-income countries (LMICs) versus high-income countries (HICs) in critically ill patients with COVID-19 and its impact on in-hospital mortality. Methods: International observational study conducted in 43 countries. Stroke and mortality incidence rates and rate ratios (IRR) were calculated per admitted days using Poisson regression. Inverse probability weighting (IPW) was used to address the HICs vs. LMICs imbalance for confounders. Results: 23,738 patients [20,511(86.4 %) HICs vs. 3,227(13.6 %) LMICs] were included. The incidence stroke/1000 admitted-days was 35.7 (95 %CI = 28.4–44.9) LMICs and 17.6 (95 %CI = 15.8–19.7) HICs; ischemic 9.47 (95 %CI = 6.57–13.7) LMICs, 1.97 (95 %CI = 1.53, 2.55) HICs; hemorrhagic, 7.18 (95 %CI = 4.73–10.9) LMICs, and 2.52 (95 %CI = 2.00–3.16) HICs; unspecified stroke type 11.6 (95 %CI = 7.75–17.3) LMICs, 8.99 (95 %CI = 7.70–10.5) HICs. In regression with IPW, LMICs vs. HICs had IRR = 1.78 (95 %CI = 1.31–2.42, p &lt; 0.001). Patients from LMICs were more likely to die than those from HICs [43.6% vs 29.2 %; Relative Risk (RR) = 2.59 (95 %CI = 2.29–2.93), p &lt; 0.001)]. Patients with stroke were more likely to die than those without stroke [RR = 1.43 (95 %CI = 1.19–1.72), p &lt; 0.001)]. Conclusions: Stroke incidence was low in HICs and LMICs although the stroke risk was higher in LMICs. Both LMIC status and stroke increased the risk of death. Improving early diagnosis of stroke and redistribution of healthcare resources should be a priority. Trial registration: ACTRN12620000421932 registered on 30/03/2020

Correction: Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies (Critical Care, (2023), 27, 1, (3), 10.1186/s13054-022-04294-5)

Following publication of the original article [1], the authors identified that the collaborating authors part of the collaborating author group CCCC Consortium was missing. The collaborating author group is available and included as Additional file 1 in this article